Two-year Longitudinal Changes in Forearm Cortical Bone Geometry in Postmenopausal Women with Mild Primary Hyperparathyroidism without Parathyroidectomy

被引:2
作者
Kaji, H. [1 ]
Yamauchi, M. [2 ]
Nomura, R. [1 ]
Sugimoto, T. [2 ]
机构
[1] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol,Chuo Ku, Kobe, Hyogo 6500017, Japan
[2] Shimane Univ, Fac Med, Izumo, Shimane, Japan
关键词
primary hyperparathyroidism; bone geometry; bone mineral density; osteoporosis; hypoparathyroidism; QUANTITATIVE COMPUTED-TOMOGRAPHY; MINERAL DENSITY; HORMONE; HYPOPARATHYROIDISM; PRESERVATION; SURGERY; DISEASE; MASS;
D O I
10.1055/s-0028-1102924
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several studies suggest that mild PTH excess does not have any deteriorative effects on bone mineral density (BMD) in several-year-longitudinal studies of patients with mild primary hyperparathyroidism (pHPT) without parathyroidectomy (PTX). However, it remains unknown about the change in bone geometry in pHPT patients without PTX. We examined the longitudinal effects of mild PTH excess on cortical bone geometry in postmenopausal patients with mild pHPT without PTX by using peripheral quantitative computed tomography (pQCT), and we compared them with normal and hypoparathyroidism women. Nine postmenopausal female patients who were diagnosed as pHPT, six postmenopausal female patients with hypoparathyroidism (3 idiopathic and 3 postoperative), and thirty postmenopausal control subjects participated in this study. Radial volumetric (v) BMD and several bone geometry parameters were measured by pQCT at basal line and after 2 years. Cortical vBMD was significantly lower in pHPT group. Moreover, total area and periosteal circumferences were significantly higher in pHPT group. Total and cortical vBMD were significantly decreased after 2 years in control group. However, they were stable in pHPT group after 2-year follow-up. As for bone geometry, cortical thickness and area were also stable in pHPT group during 2-year follow-up, although they were significantly reduced in control group and hypoparathyroidism group. In conclusion, the present longitudinal study revealed that there were no significant changes in radial vBMD and cortical bone geometry in postmenopausal women with mild pHPT, whereas age-related thinning of cortical bone as well as decrease of vBMD were observed in the control and patients with hypoparathyroidism.
引用
收藏
页码:633 / 636
页数:4
相关论文
共 30 条
[1]   BONE-MINERAL DENSITY IN PATIENTS WITH CHRONIC HYPOPARATHYROIDISM [J].
ABUGASSA, S ;
NORDENSTROM, J ;
ERIKSSON, S ;
SJODEN, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (06) :1617-1621
[2]   Bone loss and bone size after menopause [J].
Ahlborg, HG ;
Johnell, O ;
Turner, CH ;
Rannevik, G ;
Karlsson, MK .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (04) :327-334
[3]   Repeated in vivo determinations of bone mineral density during parathyroid hormone treatment in ovariectomized mice [J].
Andersson, N ;
Lindberg, MK ;
Ohlsson, C ;
Andersson, K ;
Ryberg, B .
JOURNAL OF ENDOCRINOLOGY, 2001, 170 (03) :529-537
[4]   Bone strength in primary hyperparathyroidism [J].
Bilezikian, JP .
OSTEOPOROSIS INTERNATIONAL, 2003, 14 (Suppl 5) :S113-S115
[5]   Effect of primary hyperparathyroidism on volumetric bone mineral density and bone geometry assessed by peripheral quantitative computed tomography in postmenopausal women [J].
Charopoulos, I ;
Tournis, S ;
Trovas, G ;
Raptou, P ;
Kaldrymides, P ;
Skarandavos, G ;
Katsalira, K ;
Lyritis, GP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (05) :1748-1753
[6]   Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects [J].
Chen, QX ;
Kaji, H ;
Iu, MF ;
Nomura, R ;
Sowa, H ;
Yamauchi, M ;
Tsukamoto, T ;
Sugimoto, T ;
Chihara, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (10) :4655-4658
[7]   On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism [J].
Dempster, DW ;
Parisien, M ;
Silverberg, SJ ;
Liang, XG ;
Schnitzer, M ;
Shen, V ;
Shane, E ;
Kimmel, DB ;
Recker, R ;
Lindsay, R ;
Bilezikian, JP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (05) :1562-1566
[8]   ATTENUATION OF POSTMENOPAUSAL HIGH TURNOVER BONE LOSS IN PATIENTS WITH HYPOPARATHYROIDISM [J].
FUJIYAMA, K ;
KIRIYAMA, T ;
ITO, M ;
NAKATA, K ;
YAMASHITA, S ;
YOKOYAMA, N ;
NAGATAKI, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (07) :2135-2138
[9]   BODY-WEIGHT AND BONE-MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH PRIMARY HYPERPARATHYROIDISM [J].
GREY, AB ;
EVANS, MC ;
STAPLETON, JP ;
REID, IR .
ANNALS OF INTERNAL MEDICINE, 1994, 121 (10) :745-749
[10]  
JIMENEZ LE, 1984, CALCIFIED TISSUE INT, V36, P14, DOI 10.1007/BF02405288